A Japanese health ministry panel has endorsed two products using iPS cells, paving the way for the world's first practical ...

Japan's health ministry has announced formal approval for the domestic manufacture and sale of two products for the treatment of heart disease and Parkinson's disease using iPS cells. It means such ...

Conditional approval marks a global milestone in regenerative medicine; treatments could reach patients this summer - Anadolu ...

Japan has formally approved the world’s first regenerative medical products utilizing induced pluripotent stem (iPS) cells, paving the way for use in patients as early as this summer.

Japan has approved ground-breaking stem-cell treatments for Parkinson's and severe heart failure, one of the manufacturers and media reports said Friday, with the therapies expected to reach patients ...

A Parkinson's disease treatment based on induced pluripotent stem cells (iPS) has been officially approved in Japan – as announced by ...

Japan's health ministry said Friday it has conditionally approved the production and sales of two regenerative medical products using induced pluripotent stem cells. The approval was given to ...

Japan is brimming with signs of an approaching medical revolution. Shiny white robots are tending dishes of cells, rows of incubators hum in new facilities, and a deluxe, plush-carpeted hospital is ...

Three lines of GMP iPS Cells derived from type O female blood are now offered as off-the-shelf product It is well known that HLA homozygous iPSCs are often selected to reduce adverse immune response ...

Induced pluripotent stem cells (iPS cells) can be created from any tissue in the human body and possess the ability to transform into a wide range of tissues. Kobe University MARUYAMA Tatsuo and his ...